Holen Sie sich die Stockscreener-App
207.32
4.43%
8.80
Handel nachbörslich:
207.32
Schlusskurs vom Vortag:
$198.52
Offen:
$216.66
24-Stunden-Volumen:
1.35M
Relative Volume:
0.85
Marktkapitalisierung:
$34.60B
Einnahmen:
$16.63B
Nettoeinkommen (Verlust:
$1.39B
KGV:
25.70
EPS:
8.0674
Netto-Cashflow:
$2.12B
1W Leistung:
-1.51%
1M Leistung:
+21.04%
6M Leistung:
-11.89%
1J Leistung:
+6.73%
1-Tages-Spanne:
$204.15
$217.05
1-Wochen-Bereich:
$197.60
$217.05
52-Wochen-Spanne:
$154.50
$247.04
Iqvia Holdings Inc Stock (IQV) Company Profile
Firmenname
Iqvia Holdings Inc
Sektor
Branche
Telefon
919-998-2000
Adresse
2400 ELLIS ROAD, DURHAM, NC
Compare IQV vs TMO, DHR, IDXX, A, NTRA
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
207.32 | 33.13B | 16.63B | 1.39B | 2.12B | 8.0674 |
TMO
Thermo Fisher Scientific Inc
|
572.32 | 195.64B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
192.50 | 125.93B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
539.37 | 42.99B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
139.74 | 37.69B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
264.69 | 37.84B | 2.50B | -226.32M | 71.51M | -1.6412 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-09 | Hochstufung | TD Cowen | Hold → Buy |
| 2026-03-06 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2026-03-03 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-11-03 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-10-29 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-10-09 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-09-09 | Hochstufung | Jefferies | Hold → Buy |
| 2025-04-25 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-04-10 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-02-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-12-20 | Eingeleitet | Stephens | Overweight |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-09-04 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2024-06-06 | Eingeleitet | Goldman | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-15 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-02-13 | Eingeleitet | BTIG Research | Buy |
| 2023-11-02 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-03-17 | Eingeleitet | Truist | Buy |
| 2022-12-06 | Eingeleitet | Cowen | Outperform |
| 2022-11-17 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-15 | Eingeleitet | SVB Leerink | Outperform |
| 2022-05-24 | Eingeleitet | Guggenheim | Buy |
| 2022-04-29 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-16 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-03-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2020-07-07 | Eingeleitet | Stephens | Equal-Weight |
| 2020-03-02 | Eingeleitet | Deutsche Bank | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-12-13 | Hochstufung | CFRA | Sell → Hold |
| 2019-11-14 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-06-21 | Hochstufung | Mizuho | Neutral → Buy |
| 2019-05-28 | Eingeleitet | SVB Leerink | Outperform |
| 2019-01-18 | Hochstufung | Jefferies | Hold → Buy |
| 2018-10-09 | Eingeleitet | UBS | Buy |
| 2018-10-02 | Bestätigt | Robert W. Baird | Outperform |
| 2018-07-25 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-07-25 | Bestätigt | Stifel | Buy |
| 2018-07-03 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-04-13 | Hochstufung | Goldman | Neutral → Buy |
| 2018-03-07 | Hochstufung | SunTrust | Hold → Buy |
| 2018-01-19 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Iqvia Holdings Inc Aktie (IQV) Neueste Nachrichten
IQVIA Holdings Inc (IQV) Shares Surge 4.4% -- What GF Score of 86 Tells Investors - GuruFocus
Why IQVIA (IQV) Stock Is Up Today - Quiver Quantitative
IQVIA BDR program executes 4-for-1 stock split in Brazil on Aug. 26 - Bitget
IQVIA Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
IQVIA Holdings stock holds its ground as investors await fresh data - Ad-hoc-news.de
IQVIA Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
IQVIA Holdings stock trades steady as data-driven growth supports recent earnings - Ad-hoc-news.de
IQVIA Holdings (IQV) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
IQVIA Holdings (IQV) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
IQVIA Holdings (IQV) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
IQVIA Holdings (QTS) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
IQVIA Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
IQVIA Holdings stock trades steadily as data-driven healthcare growth supports valuation - Ad-hoc-news.de
(IQV) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
IQVIA stock trades steady as data-driven growth supports long term earnings story - Ad-hoc-news.de
IQVIA (IQV) Goes To Congress Over Early Clinical Development Rules - Sahm
IQVIA Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
IQVIA Holdings stock trades steadily as data-driven growth supports valuations - Ad-hoc-news.de
Is IQVIA Holdings stock outperforming the Dow? - MSN
Form 4 IQVIA Holdings Inc For: 16 July By Investing.com - Investing.com Nigeria
IQVIA Holdings (NYSE: IQV) grants director 148 deferred shares - Stock Titan
IQVIA Holdings (NYSE: IQV) grants director 183 deferred shares - Stock Titan
IQVIA Holdings (NYSE: IQV) grants director 195 deferred shares - Stock Titan
IQVIA Holdings (NYSE: IQV) awards director 160 deferred share units - Stock Titan
IQVIA Holdings Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
IQVIA Seeks Faster Path From Discovery to Human Drug Trials - Stock Titan
IQVIA Holdings' Q2 2026 earnings: What to expect - MSN
Frontier tech research, news & data - MLQ.ai
IQVIA Holdings (IQV) Q1 2026 Earnings Call Transcript - Fortune
Global Clinical Trials Market to Reach $176.32 Billion by 2030 as AI and Decentralized Research Accelerate Growth - GlobeNewswire Inc.
IQVIA Holdings stock reflects data-driven growth in global healthcare analytics - ad-hoc-news.de
IQV vs. PEN: Which Stock Is the Better Value Option? - Yahoo! Finance Canada
IQVIA stock holds steady as its data and research model stays central - ad-hoc-news.de
IQVIA Holdings Inc. (IQV) Q1 2026 Earnings: EPS Surpasses Street Estimates, Shares Edge HigherGuidance Accuracy Score - dars.gov.et
Mizuho Adjusts Price Target on IQVIA Holdings to $230 From $215, Maintains Outperform Rating - marketscreener.com
Mizuho Securities Maintains IQVIA Holdings(IQV.US) With Buy Rating, Raises Target Price to $230 - Moomoo
IQV Maintained by Mizuho -- Price Target Raised to $230 - GuruFocus
IQVIA Holdings, Inc. (IQV) Stock Analysis: Strong Analyst Consensus and a 10% Upside Potential - DirectorsTalk Interviews
IQVIA stock steadies as data-driven health services underpin long-term growth - Ad-hoc-news.de
Why is Larry Robbins Bullish on IQVIA Holdings (IQV) Amid Market Volatility - Kavout | AI
Analysts Are Neutral on Top Healthcare Stocks: IQVIA Holdings (IQV), Qiagen (QGEN) - The Globe and Mail
IQVIA HOLDINGS INC CMNRo Khanna Congressional Trade on Jun. 02, 2026 - Quiver Quantitative
Did Artisan’s New Stake in IQVIA (IQV) Reframe Its AI and Data Recurring-Revenue Story? - Sahm
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MSN
IQV News | IQVIA HOLDINGS INC (NYSE:IQV) - ChartMill
IQVIA stock stays supported by data-driven healthcare demand - ad-hoc-news.de
IQVIA (IQV) Just Drew A New Artisan Partners Bet On AI And Resilience - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
IQVIA Holdings stock stays supported by data-driven healthcare demand - ad-hoc-news.de
IQVIA Holdings (IQV) Draws Undervalued Attention, Is The Recent Momentum Fully Priced In? - Sahm
IQVIA to Announce Second-Quarter 2026 Results on July 28, 2026 - BioSpace
Finanzdaten der Iqvia Holdings Inc-Aktie (IQV)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):